Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein
Introduction
Prostate cancer ranks as the second leading cause of adult male deaths from cancer in the United States [1]. In contrast, Asian men who consume a traditional diet high in soy products, have a relatively low incidence and mortality of prostate cancer [2]. It has also been reported that high consumption of soymilk are associated with reduced risk of prostate cancer [3]. Genistein is a prominent isoflavone found in soybean, and has been proposed to be responsible for lowering the incidence of prostate cancer in Asian men [2], [4]. Our previous studies have shown that genistein inhibits the growth of PC3 prostate cancer cells and induces apoptosis by inhibiting NF-κB and Akt signaling pathways [5], [6]. Moreover, we found that genistein inhibits the expression of c-erbB2 and MMP-9 which play important roles in the processes of tumor cell invasion and metastasis [7], suggesting that genistein elicits pleiotropic effects on cancer cells.
Once prostate cancer is diagnostically confirmed, the most significant threat to patient's survival and quality of life is primarily contributed by the presence of occult metastasis, which eventually kills the patient [8]. This is partly because of the disappointing results of chemotherapy for the treatment of prostate cancer [9]. Thus, there is a tremendous need for the development of mechanism-based and targeted therapeutic strategies for prostate cancer, particularly for metastatic prostate cancer. cDNA microarray analysis permits the analysis for the expression of tens of thousands of genes to be monitored simultaneously and rapidly [10], which provides a window of opportunity for determining the effects of anti-cancer agent on cancer cells. This will contribute in devising therapeutic strategies more accurately and to determine the molecular mechanism(s) of action of therapeutic agents. In order to better understand the precise molecular mechanism(s) by which genistein exerts its effects on PC3 prostate cancer cells, we have utilized cDNA microarray to determine the gene expression profile altered by genistein treatment. In this report, we focused on the genes which are known to play important roles in the control of angiogenesis, tumor cell invasion and metastasis.
Section snippets
Cell culture and growth inhibition
PC3 human prostate cancer cells (ATCC, Manassas, VA) were cultured in RPMI-1640 media (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum and 1% penicillin and streptomycin in a 5% CO2 atmosphere at 37 °C. Genistein (Toronto Research Chemicals, North York, Ontario, Canada) was dissolved in 0.1 M Na2CO3 to make a 10 mM stock solution for experiments. For growth inhibition, PC3 cells were treated with 5, 15, 30, and 50 μM genistein or 0.5 mM Na2CO3 (vehicle control) for 1–3 days.
Cell growth inhibition by genistein treatment
MTT assay showed that the treatment of PC3 prostate cancer cells with genistein resulted in a dose and time-dependent inhibition of cell proliferation (Fig. 1), demonstrating the inhibitory effect of genistein on PC3 cell growth. These results are consistent with our previous results [11]. Inhibition of cell proliferation observed by MTT could be due to the regulation of gene expression by genistein treatment. We, therefore, investigated the gene expression profile of PC3 prostate cancer cells
Discussion
Genistein is known as a protein tyrosine kinase inhibitor [12]. In addition, our previous studies along with the studies reported by other investigators have shown that genistein may exert multiple inhibitory effects on cancer cells through regulation of several cell signal transduction pathways including NF-κB, Akt, MEKK, etc. [5], [6], [13]. In the present study, the gene expression profile of PC3 prostate cancer cells exposed to genistein revealed that genistein regulated the transcription
Acknowledgements
This work was partly funded by a grant from the National Cancer Institute, NIH (CA83695-O1A2 awarded to F.H.S.) and was also supported by an unrestricted grant from RGK foundation.
References (28)
Prognostic and predictive factors in prostate cancer
Cancer Treat. Rev.
(2001)- et al.
Genistein, a specific inhibitor of tyrosine-specific protein kinases
J. Biol. Chem.
(1987) - et al.
Regulation of BCR- and PKC/Ca(2+)-mediated activation of the Raf1/MEK/MAPK pathway by protein-tyrosine kinase and -tyrosine phosphatase activities
Mol. Immunol.
(1996) - et al.
The role of the plasminogen activation system in angiogenesis and metastasis
Surg. Oncol. Clin. North Am.
(2001) - et al.
Differential expression of protease-activated receptors-1 and -2 in stromal fibroblasts of normal, benign, and malignant human tissues
Am. J. Pathol.
(2001) - et al.
Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis
J. Nutr.
(1995) - et al.
Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice
J. Nutr.
(1999) - et al.
Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends
J. Natl. Cancer Inst.
(2001) - et al.
Soybean phytoestrogen intake and cancer risk
J. Nutr.
(1995) - et al.
Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States)
Cancer Causes Control
(1998)
Effect of genistein on in vitro and in vivo models of cancer
J. Nutr.
Genistein inhibits NF-kappa B activation in prostate cancer cells
Nutr. Cancer
Inhibition of NF-kB activation in PC3 cells by genistein is mediated via Akt signaling pathway
Clin. Cancer Res.
Induction of apoptosis and inhibition of c-erbB-2 in MDA-MB-435 cells by genistein
Int. J. Oncol.
Cited by (112)
-
The multimodal action of genistein in Alzheimer's and other age-related diseases
2022, Free Radical Biology and Medicine -
A modern era of personalized medicine in the diagnosis, prognosis, and treatment of prostate cancer
2020, Computers in Biology and MedicineCitation Excerpt :Genistein targets the AR-mediated pathways and recent studies on lncRNAs showed that HOTAIR was highly regulated by genistein because its expression was higher coupled with miR-34a in CRPC cell lines without control [49,50]. Apart from coding genes, transcripts of non-coding genes can also serve as an effective biomarker for predicting PCa [49,50]. Studies have shown that the non-coding gene PCA3 was found to be upregulated in PCa with high sensitivity and specificity when compared with BPH based on PSA detection.
-
Genistein protects against acute pancreatitis via activation of an apoptotic pathway mediated through endoplasmic reticulum stress in rats
2019, Biochemical and Biophysical Research Communications -
Live or let die: Neuroprotective and anti-cancer effects of nutraceutical antioxidants
2018, Pharmacology and Therapeutics -
The effect of genistein on TGF-β signal, dysregulation of apoptosis, cyclooxygenase-2 pathway, and NF-kB pathway in mice peritoneum of endometriosis model
2017, Middle East Fertility Society Journal